Valerio Therapeutics SA
PAR:ALVIO

Watchlist Manager
Valerio Therapeutics SA Logo
Valerio Therapeutics SA
PAR:ALVIO
Watchlist
Price: 0.141 EUR -0.7% Market Closed
Market Cap: 68.9m EUR

Wall Street
Price Targets

ALVIO Price Targets Summary
Valerio Therapeutics SA

There are no price targets for ALVIO.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Valerio Therapeutics SA Competitors:
Price Targets
INSM
Insmed Inc
35% Upside
688180
Shanghai Junshi Biosciences Co Ltd
28% Downside
SYNACT
SynAct Pharma AB
11% Upside
196170
Alteogen Inc
4% Upside
ZNTL
Zentalis Pharmaceuticals Inc
83% Upside
EDIT
Editas Medicine Inc
148% Upside
BBIO
BridgeBio Pharma Inc
19% Upside
251120
Bio-FD&C Co Ltd
31% Upside

Revenue
Forecast

Revenue Estimate
Valerio Therapeutics SA

For the last 13 years the compound annual growth rate for Valerio Therapeutics SA's revenue is -4%. The projected CAGR for the next 2 years is 247%.

-4%
Past Growth
247%
Estimated Growth
Estimates Accuracy
6%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Valerio Therapeutics SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Valerio Therapeutics SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-91%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ALVIO's stock price target?
Not Available

ALVIO doesn't have any price targets made by Wall Street professionals.

What is Valerio Therapeutics SA's Revenue forecast?
Projected CAGR
247%

For the last 13 years the compound annual growth rate for Valerio Therapeutics SA's revenue is -4%. The projected CAGR for the next 2 years is 247%.

Back to Top